-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
A recent study published in Neurology, an authoritative journal in the field of neurology, was designed to describe short-term and five-year mortality and adverse outcomes in patients with spontaneous aneurysm subcrystrial haemorrhage (aSAH) who received repair therapy.
in this forward-looking observational study, the researchers analyzed mortality and adverse outcomes in 311 aSAH patients over a three-month, one-year and five-year follow-up (the improved Rankin scale scored 3-6).
sensitivity analysis is carried out according to the treatment method.
researchers analyzed the subjects' hospitalization and five years of complications.
347 patients (72.9%) were aSAH out of 476 patients who were treated continuously for subcity hemorrhage in the cobwebs.
311 (89.6%) of these patients received treatment (242 intravascular treatments and 69 neurosurgery treatments) and the subjects followed them for an average of 43.4 months (1 to 145).
mortality rates were 18.4 per cent, 22.9 per cent and 29.0 per cent, respectively, and the rates of adverse outcomes were 42.3 per cent, 36.0 per cent and 36.0 per cent, respectively.
-adjusted adverse outcomes were lower than neurosurgery treatment three months after intravascular therapy, with an absolute difference of 15.8% and an absolute difference of 15.9% over a one-year period.
in both groups, the number of people in need of treatment was 6.3.
the ratio of intravascular therapy (OR) was 0.36 (95% CI is 0.18-0.74) and neurosurgery treatment was 0.40 (95% CI was 0.20-0.81).
there was no significant difference between the two treatments.
, patients treated with in-vascular techniques were less likely to have mechanical breathing (OR=0.67 (95% CI is 0.54-0.84).
result, the short-term mortality rate for patients treated with aSAH under current guidelines was 18.4 per cent and the five-year mortality rate was 29 per cent.
the majority of patients (64.0%) survived the five-year follow-up and did not have a disability.
patients who prioritized intravascular therapy had better outcomes than those who had neurosurgery.
.
